Study of Airflow in the Lungs Using Helium MRI

University of Virginia

Status

Active, not recruiting

Conditions

Healthy

Constrictive Bronchitis

COPD

Treatments

Drug: hyperpolarized helium MRI of the chest

Study type

Interventional

Funder types

Other

Identifiers

NCT02154568

16885

W81XWH-09-2-0027 (Other Grant/Funding Number)

Details and patient eligibility

About

Computer simulations are being developed to predict air flow abnormalities in the airways of patients with lung disease. The purpose of this study is to obtain actual gas flow measurements in the lungs of healthy patients and patients with lung disease and use these measurements to validate the computer models.

Full description

The Biotechnology High Performance Computing Software Applications Institute (BHSAI) of the Department of Defense (DoD) is studying airflow in the lungs using computational fluid dynamics in order to characterize disease-specific airflow patterns and provide useful information for medical applications. To validate these models, they are seeking to obtain experimental data of airflow in human lungs, both healthy and diseased. An assessment of airflow can be obtained by using hyperpolarized noble gas (HNG) magnetic resonance imaging (MRI) or, more specifically, hyperpolarized helium-3 (HHe) MRI in conjunction with flow-encoding schemes that are well-established in conventional proton MRI

Four chronic obstructive pulmonary disease (COPD) patients and four healthy subjects will undergo pulmonary function tests (PFTs), computed tomography (CT) scan covering the mouth, neck, and chest, and hyperpolarized helium 3 MRI. Before and after the MRI scans, three spirometry readings will be taken while the subject is lying in the same position as in the MR scanners. Data will be analyzed by the BHSAI. UVa will provide the de-identified raw image data and the de-identified results of the spirometry and other tests to BHSAI

Enrollment

10 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy subjects:
- Normal PFT values: FEV1 > 90% predicted; and Forced vital capacity (FVC) > 90% predicted
- Normal chest x-ray (CXR)
- Medical history: No active pulmonary symptoms (cough, shortness of breath, sputum); Negative history of pulmonary disease; Negative smoking history (never smoked)
Pulmonary Disease Subjects:
- PFT values: FEV1/FVC < 70% (indicative of obstruction); and 30% < FEV1 < 50% predicted
- CXR normal except hyperinflation
- Symptoms - chronic shortness of breath
All test subjects, healthy and with COPD should have similar physical anthropometric characteristics:
- Similar age with age difference less than 3 years
- Similar height (within 3-4 inches)

Exclusion criteria

Any condition for which a MRI procedure is contraindicated.
Presence of any non-MRI compatible metallic material in the body, such as pacemakers, metallic clips, etc.
Likelihood of claustrophobia
Chest circumference greater than that of the helium MR coil.
Pregnancy, by report of subject. Clinically in the Department of radiology at UVA, self report is used when screening patients for MR scans as well as CT scans and fluoroscopy studies. If the subject reports there is any chance of their being pregnant a urine pregnancy test will be performed prior to any imaging.